WENA - צמיחת הכנסות שנתית ב-12 החודשים האחרונים Anew Medical Inc.

Anew Medical, Inc. (WENA) is advancing gene therapy through partnerships with European centers, accelerating the licensing of patents. The last twelve months (LTM) revenue growth rate links these achievements to the implementation of ESG standards for chemical disposal, where describes the current status of the metric. Business stability relies on a compact staff of scientists motivated by equity ownership in the company.
Anew Medical - פילוחים אנליטיים ומדדי מפתח (WENA)

Revenue dynamics via the rolling annual growth rate reflect the market value of the business as a result of the continuous discounting of its future cash flows. By analyzing the trailing twelve-month sales growth, an investor assesses the operational resilience of Anew Medical, Inc. (WENA) in the context of commercializing breakthrough Klotho protein-based therapy to combat neurodegenerative diseases such as ALS and Alzheimer's.